[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Trisalus Life Sciences Inc (TLSI)

Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trisalus Life Sciences Inc 6272 W 91st Ave Westminster CO 80031 USA

www.trisaluslifesci.com Employees: 102 P: 888-321-5212

Sector:

Medical

Description:

TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.

Key Statistics

Overview:

Market Capitalization, $K 199,858
Enterprise Value, $K 212,468
Shares Outstanding, K 61,306
Float, K 51,313
% Float 83.70%
Short Interest, K 1,442
Short Float 2.35%
Days to Cover 12.25
Short Volume Ratio 0.61
% of Insider Shareholders 16.30%
% of Institutional Shareholders 2.58%

Financials:

Annual Sales, $ 45,150 K
Annual Net Income, $ -39,230 K
Last Quarter Sales, $ 8,900 K
Last Quarter Net Income, $ 1,540 K
EBIT, $ -28,020 K
EBITDA, $ -26,340 K

Growth:

1-Year Return -39.07%
3-Year Return -68.68%
5-Year Return -66.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 05/12/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -1.49
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year 57.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TLSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -69.91%
Profit Margin % -86.89%
Debt/Equity 2.58
Price/Sales 4.68
Price/Cash Flow N/A
Price/Book 16.51
Book Value/Share 0.21
Interest Coverage -6.08
60-Month Beta 0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.